Consumer Perception of Out-of-pocket Prescription Drug Costs and Consumer Willingness to Choose Inexpensive Drugs

Park, Sylvia; Lee, Na-Gyeong

Full metadata record

DC Field	Value
dc.contributor.author	Park, Sylvia
dc.contributor.author	Lee, Na-Gyeong
dc.date.accessioned	2021-06-11T03:57:34Z
dc.date.available	2021-06-11T03:57:34Z
dc.date.issued	2021-06-11
dc.identifier.uri	https://repository.kihasa.re.kr/handle/201002/37847
dc.description.abstract	Inasmuch as raising the efficiency of pharmaceutical expenditures is an important policy goal toward keeping the National Health Insurance financially sustainable, off-patent drugs are regarded as a market with significant potential. Pharmaceutical expenditures have been growing more rapidly in Korea than in any other OECD country. It is crucial thus to add efficiency to Korea’s pharmaceutical expenditures. In theory, using generics in place of off-patent brand-name drugs, as long as they have the same clinical effect, can be conducive to reducing pharmaceutical spending. The larger the range of drugs of the same active ingredients and pharmaceutical formulation, the more likely it is that the prices of these products will fall through competition.
dc.format	image/jpeg
dc.format	application/pdf
dc.format.extent	10
dc.language	eng
dc.publisher	Korea Institute for Health and Social Affairs
dc.rights	KOGL BY-NC-ND
dc.rights.uri	https://creativecommons.org/licenses/by-nc-nd/2.0/kr/
dc.rights.uri	http://www.kogl.or.kr/info/licenseType4.do
dc.title	Consumer Perception of Out-of-pocket Prescription Drug Costs and Consumer Willingness to Choose Inexpensive Drugs
dc.type	Article
dc.type.local	Article(Series)
dc.description.eprintVersion	published
dc.citation.title	Research in Brief
dc.citation.number	77
dc.citation.date	2021-06-11
dc.citation.startPage	1
dc.citation.endPage	10
dc.identifier.bibliographicCitation	Research in Brief, no. 77, pp. 1 - 10
dc.date.dateaccepted	2021-06-11T03:57:34Z
dc.date.datesubmitted	2021-06-11T03:57:34Z